CP and oral lichen planus: With high potency and increased retention in tissue, CP is frequently the choice for the therapeutic management of OLP (1), and so we selected this corticosteroid for incorporation into a novel electrospun mucoadhesive oral patch intended for localized, unidirectional delivery to the oral mucosa (25).